TickerFactsScreenerDevelopers

TransMedics Group, Inc. (TMDX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2018: -$25.98M2019: -$32.29M2020: -$30.27M2021: -$28.86M2022: -$45.82M2023: -$13.03M2024: $48.80M2025: $192.84M$192.84M
2018Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$192.84M+295.1%
2024$48.80M+474.6%
2023-$13.03M+71.6%
2022-$45.82M-58.7%
2021-$28.86M+4.6%
2020-$30.27M+6.3%
2019-$32.29M-24.3%
2018-$25.98M—